Jeff Geschwind’s work on tumor metabolism has transformed liver cancer care, especially when paired with Cone Beam CT during TACE. His clinical approach integrates metabolic targeting with real-time imaging, allowing highly selective treatment delivery. This combination enhances precision, improves tumor response, and supports better long-term outcomes for complex hepatic malignancies. https://www.bumc.bu.edu/camed/offices-services/alumni/alumni-recognition-resources/alumni-awards-submission/past-recipients-of-the-alumni-awards/jean-francois-jeff-geschwind-m-d-91-2011-distinguished-alumnus-award/